Repository logo
  • English
  • ไทย
Log In
New user? Click here to register. Have you forgotten your password?
Communities & Collections
All of Mahidol IR
Mahidol Journals
Statistics
About Us
Customer Feedback
Deposit
  1. Home

Browsing by Author "S. Watcharananan"

Filter results by typing the first few letters
Now showing 1 - 2 of 2
  • Results Per Page
  • Sort Options
  • No Thumbnail Available
    PublicationMetadata only
    Predicting factors for unsuccessful switching from nevirapine to efavirenz in HIV-infected patients who developed nevirapine-associated skin rash
    (2009-03-01) S. Kiertiburanakul; K. Malathum; S. Watcharananan; B. Sathapatayavongs; S. Sungkanuparph; Mahidol University
    Summary: Skin rash associated with nevirapine (NVP) is common and efavirenz (EFV) is often used as a substitute. We aimed to determine the predicting factors for unsuccessful switching from NVP to EFV. A retrospective cohort study was conducted in HIV-infected patients who developed rash after taking NVP. There were 109 patients with a mean standard deviation (SD) age of 36.6 (7.4) years and 45% were males. Median (interquartile range) CD4 cell count and HIV RNA at the time of NVP initiation were 163 (50-273) cells/mm3and 4.6 (1.7-5.4) log copies/mL, respectively. Twenty (18.3%) patients subsequently developed EFV-associated rash. By logistic regression, history of drug allergy apart from NVP (odds ratio [OR] 11.42) and CD4 cell count,100 cells/mm3(OR 6.14) were significant predicting factors for EFV-associated rash. Two predicting factors for unsuccessful switching from NVP to EFV were found. Patients who have these factors need to have a close follow-up if EFV is substituted.
  • No Thumbnail Available
    PublicationMetadata only
    Severe nonfebrile dengue infection in an adolescent after postoperative kidney transplantation: A case report
    (2012-01-01) K. Tangnararatchakit; W. Tirapanich; W. Tapaneya-Olarn; V. Sumethkul; N. Sirachainan; S. Watcharananan; C. Leenanupunth; S. Yoksan; A. Chuansumrit; Mahidol University
    We herein have reported a case of severe nonfebrile dengue infection complicated with refractory pancytopenia and a large perinephric hematoma with shock in a 16-year-old adolescent during the early postoperative period after kidney transplantation. After the diagnosis of end-stage renal disease she underwent living-related kidney transplantation. Thirteen days after successful transplantation, she exhibited a notable amount of ascites, bilateral pleural effusions, thrombocytopenia, and increased hemoglobin without pre-existent fever. Further investigation revealed positive dengue nonstructural protein 1 antigen (dengue NS1 Ag) and dengue virus serotype 1 by a reverse transcriptase-polymerase chain reaction (RT-PCR) in the patient's serum. She exhibited hemophagocytic syndrome, manifested by refractory pancytopenia and refractory anemia resulting in hypovolemic shock and acute graft failure on day 28 posttransplantation. The anemia was attributed to a large hematoma around the transplanted kidney requiring surgical evacuation of clotted blood. Postoperatively, she gradually recovered with resolution of thrombocytopenia and excellent graft function. Persistent dengue antigenemia and viremia was shown by dengue NS1 Ag and RT-PCR of dengue serotype-1. The viremia was present longer than the dengue antigenemia. Dengue-specific immunoglobulin M (IgM) and IgG by enzyme-linked immunosorbent assay confirmed the primary dengue infection and evidence of a recent donor dengue infection. © 2012 Published by Elsevier Inc.

Contact Us

Mahidol University Library and Knowledge Center.

Mahidol University Repository Division, Scholarly Resources Department

Office Hour: Monday-Friday 08.30-12.00 and 13.00-16.30 hrs.
Phutthamonthon Sai 4 Rd. Salaya, Nakhon Pathom 73170, Thailand
The office: +66 (2) 800 2680 ext.4306
thipsuda.van@mahidol.ac.th
https://repository.li.mahidol.ac.th
Except where otherwise noted, content on this site is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International license.
  • Privacy Notice
  • Term of use